MAPK1 and Alzheimer disease: Luteolin also exerts neuroprotective effects by preventing Aβ-induced cell death via an anti-oxidant mechanism and upregulation of ER/ERK/MAPK signaling pathway in in vitro models of AD [55, 61, 69, 70].